Inventor · disambiguated record
Oren T. Mcnulty
Also filed as: MCNULTY OREN T · MCNULTY OREN TEAGUE
17 granted patents·6 pending applications·82 citations·filing 2017–2024
93Inventor score
Files withARRAY BIOPHARMA INC23
Top patents by PatentIndex Score
23 records- 0198US10112942B2Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitorsARRAY BIOPHARMA INC·Filed 2017·Granted Oct 30, 2018·29 cites·30 claims
- 0297US10953005B1Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitorsARRAY BIOPHARMA INC·Filed 2020·Granted Mar 23, 2021·4 cites·16 claims
- 0397US10137124B2Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitorsARRAY BIOPHARMA INC·Filed 2018·Granted Nov 27, 2018·12 cites·29 claims
- 0496US10172851B2Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitorsARRAY BIOPHARMA INC·Filed 2018·Granted Jan 8, 2019·8 cites·29 claims
- 0594US10555944B2Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitorsARRAY BIOPHARMA INC·Filed 2018·Granted Feb 11, 2020·10 cites·12 claims
- 0691US10172845B2Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitorsARRAY BIOPHARMA INC·Filed 2018·Granted Jan 8, 2019·4 cites·29 claims
- 0789US11634417B2Protein tyrosine phosphatase inhibitorsARRAY BIOPHARMA INC·Filed 2020·Granted Apr 25, 2023·2 cites·52 claims
- 0889US10144734B2Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitorsARRAY BIOPHARMA INC·Filed 2017·Granted Dec 4, 2018·6 cites·30 claims
- 0988US11780835B2Pyrazolo[3,4-b]pyridine compounds as inhibitors of TAM and MET kinasesARRAY BIOPHARMA INC·Filed 2021·Granted Oct 10, 2023·1 cites·9 claims
- 1088US10441581B2Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitorsARRAY BIOPHARMA INC·Filed 2018·Granted Oct 15, 2019·2 cites·29 claims
- 1187US11998545B2Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitorsARRAY BIOPHARMA INC·Filed 2023·Granted Jun 4, 2024·0 cites·14 claims
- 1284US11104676B2Pyrazolo[3,4-b]pyridine compounds as inhibitors of TAM and MET kinasesARRAY BIOPHARMA INC·Filed 2019·Granted Aug 31, 2021·1 cites·4 claims
- 1382US10881652B2Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitorsARRAY BIOPHARMA INC·Filed 2019·Granted Jan 5, 2021·2 cites·14 claims
- 1480US2023090520A1Substituted pyrazolo[1,5-a]pyridine compounds as ret kinase inhibitorsARRAY BIOPHARMA INC·Filed 2021·Application pending·0 cites
- 1579US2024124453A1Protein tyrosine phosphatase inhibitorsARRAY BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 1678US2024174666A1PYRAZOLO[3,4-b]PYRIDINE COMPOUNDS AS INHIBITORS OF TAM AND MET KINASESARRAY BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 1776US2021186959A1Substituted pyrazolo[1,5-a]pyridine compounds as ret kinase inhibitorsARRAY BIOPHARMA INC·Filed 2021·Application pending·0 cites
- 1876US2025066357A1Protein tyrosine phosphatase inhibitorsARRAY BIOPHARMA INC·Filed 2024·Application pending·0 cites
- 1975US11247990B1Bicyclic fused pyridine compounds as inhibitors of TAM kinasesARRAY BIOPHARMA INC·Filed 2018·Granted Feb 15, 2022·1 cites·20 claims
- 2074US11884664B2Protein tyrosine phosphatase inhibitorsARRAY BIOPHARMA INC·Filed 2022·Granted Jan 30, 2024·0 cites·16 claims
- 2172US11648243B2Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitorsARRAY BIOPHARMA INC·Filed 2020·Granted May 16, 2023·0 cites·20 claims
- 2263US12187721B2Protein tyrosine phosphatase inhibitorsARRAY BIOPHARMA INC·Filed 2019·Granted Jan 7, 2025·0 cites·22 claims
- 2349US2020216416A1Quinoline compounds as inhibitors of tam and met kinasesARRAY BIOPHARMA INC·Filed 2020·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →